Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
CALL
Box
BOX
$4.52B
| $7.58M | ﹤0.01% |
301,400
-157,200
| -34% | -$4.39M |
|
2977
CALL
State Street
STT
$52.7B
| $7.58M | ﹤0.01% |
122,900
-19,700
| -14% | -$1.39M |
|
2978
CALL
iShares Core S&P Total US Stock Market ETF
ITOT
$98.3B
| $7.57M | ﹤0.01% |
90,400
+41,200
| +84% | +$3.75M |
|
|
FMTX
2979
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $7.56M | ﹤0.01% |
1,097,744
+677,615
| +161% | +$4.76M |
|
2980
CALL
Ternium
TX
$10.6B
| $7.55M | ﹤0.01% |
209,300
-173,200
| -45% | -$7.36M |
|
|
DBTX
2981
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $7.55M | ﹤0.01% |
1,792,308
+18,617
| +1% | +$44K |
|
2982
CALL
CBRE Group
CBRE
$44.3B
| $7.54M | ﹤0.01% |
102,500
+9,900
| +11% | +$797K |
|
2983
PUT
Knight Transportation
KNX
$11.8B
| $7.54M | ﹤0.01% |
163,000
-26,400
| -14% | -$1.25M |
|
|
CCXI
2984
DELISTED
ChemoCentryx, Inc.
CCXI
| $7.54M | ﹤0.01% |
304,424
-1,906
| -0.6% | -$42K |
|
2985
Stellantis
STLA
$20.2B
| $7.54M | ﹤0.01% |
609,703
+10,323
| +2% | +$146K |
|
2986
PUT
Viatris
VTRS
$18.6B
| $7.53M | ﹤0.01% |
719,096
-295,820
| -29% | -$3.24M |
|
2987
CALL
Teradata
TDC
$2.57B
| $7.53M | ﹤0.01% |
203,400
-122,000
| -37% | -$4.87M |
|
|
LTC
2988
LTC Properties
LTC
$2.17B
| $7.52M | ﹤0.01% |
195,773
+53,576
| +38% | +$1.98M |
|
2989
Pinnacle Financial Partners Inc
PNFP
$16.3B
| $7.52M | ﹤0.01% |
103,936
+35,309
| +51% | +$2.79M |
|
2990
Universal Health Services
UHS
$10B
| $7.51M | ﹤0.01% |
74,619
+9,759
| +15% | +$1.22M |
|
|
JUGG
2991
DELISTED
Jaws Juggernaut Acquisition Corporation Class A Ordinary Share
JUGG
| $7.51M | ﹤0.01% |
770,342
-700,020
| -48% | -$6.82M |
|
2992
PUT
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.56B
| $7.51M | ﹤0.01% |
215,800
+168,800
| +359% | +$6.44M |
|
2993
Power Integrations
POWI
$3.51B
| $7.49M | ﹤0.01% |
99,918
-71,647
| -42% | -$5.81M |
|
2994
Werner Enterprises
WERN
$2.33B
| $7.49M | ﹤0.01% |
194,444
-216,601
| -53% | -$8.53M |
|
|
2995
CALL
Universal Health Services
UHS
$10B
| $7.49M | ﹤0.01% |
74,400
+9,400
| +14% | +$1.18M |
|
2996
PUT
Ovintiv
OVV
$17.4B
| $7.49M | ﹤0.01% |
169,500
+38,400
| +29% | +$1.98M |
|
2997
PureCycle Technologies
PCT
$1.4B
| $7.49M | ﹤0.01% |
1,009,434
+820,142
| +433% | +$6.87M |
|
|
JPXN
2998
iShares JPX-Nikkei 400 ETF
JPXN
$142M
| $7.49M | ﹤0.01% |
132,878
+16,866
| +15% | +$1.01M |
|
2999
CALL
Kimbell Royalty Partners
KRP
$1.52B
| $7.48M | ﹤0.01% |
477,000
+154,400
| +48% | +$2.69M |
|
|
PMGM
3000
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
| $7.48M | ﹤0.01% |
753,898
+218
| +0% | +$2.16K |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.